Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Massachusetts Healthcare Journal.

Healthcare Workforce Management Market Surges Amid Drive for Operational Efficiency and Cost Reduction
Boston, Aug. 04, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, the “Global Healthcare Workforce Management System Market” is expected to grow from $1.9 billion in 2024 to $3.1 billion by the end of 2029, at a compound...

Quantum BioPharma Announces Very Promising Results from the Massachusetts General Hospital Scientists on the Novel Positron Emission Tomography (PET) Tracer Used to Detect and Monitor Demyelination in Multiple Sclerosis Patients
TORONTO, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech...

Veteran Chicago pediatric neurosurgeon Arthur DiPatri, MD, joins UChicago Medicine Comer Children’s Hospital
Arthur “Art” DiPatri, MD, a veteran Chicago pediatric neurosurgeon, joined the University of Chicago Medicine on August 1 as Director of Pediatric Neurosurgery at Comer Children’s Hospital. DiPatri will also serve as Chief of Pediatric...

Atea Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update
Patient Enrollment Advances in Global Phase 3 Program for Treatment of HCV Four Scientific Posters Presented at EASL, Including Final Results from Phase 2 Study of Bemnifosbuvir/Ruzasvir Regimen Confirming 98% Sustained Virologic Response at 12...

AVITA Medical Reports Second Quarter 2025 Financial Results, Updates Full-Year Guidance, and Highlights Continued Clinical Innovation
VALENCIA, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today reported financial results for the second quarter ended...

MEDIA ALERT: GAI World 2025 Anchors Boston AI Week in September
Learn how real-world AI deployments sustain ROI at over 60 leading businesses BOSTON, MA, UNITED STATES, August 7, 2025 /EINPresswire.com/ -- WHAT: The GAI World 2025 conference will convene AI leaders from industries including life sciences,...

Disc Medicine Reports Second Quarter 2025 Financial Results and Provides Business Update
Company on track to submit NDA for bitopertin in erythropoietic protoporphyria (EPP) under accelerated approval pathway in October 2025, supported by successful pre-NDA meeting Expect initial data from Phase 2 study of DISC-0974 in patients with...

Global Medical Aesthetic Devices Market to Reach $37.9 Billion by 2029
Boston, Aug. 06, 2025 (GLOBE NEWSWIRE) -- As global demand for aesthetic enhancement rises, medical aesthetic devices are transforming how patients approach cosmetic care. From laser-based treatments to minimally invasive procedures, leading...

MiniLuxe Announces Best of Boston Award for Manicure and Pedicure Services
Boston, MA, Aug. 06, 2025 (GLOBE NEWSWIRE) -- MiniLuxe, a leader in clean beauty and self-care services, proudly announces receiving Best Manicure and Pedicure Services granted by Boston Magazine’s Best of Boston 2025. Meticulously researched by...

Debbie Peikes, an Expert in Health Care Analytics and Evaluation, Joins the American Institutes for Research
Arlington, Va., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Debbie Peikes, a nationally recognized leader in health care analytics and evaluation, has joined the American Institutes for Research (AIR) as vice president for evaluation, methods, and analytics...

ONWARD Medical Announces the Appointment of Lucas Buchanan to its Board of Directors
Buchanan is former CFO and COO of Silk Road Medical, where he successfully scaled a growth-stage medical device company, leading to an acquisition by Boston Scientific. Buchanan, formerly a venture capitalist with the Vertical Group, is also an...

Cardurion Pharmaceuticals Completes Enrollment in Phase 2 CYCLE Trials Evaluating CRD-750, a Novel PDE9 inhibitor, in Heart Failure
CRD-750 is the first clinical-stage PDE9 inhibitor to be evaluated in patients in both types of chronic heart failure The CYCLE-1-REF trial is evaluating patients with heart failure with reduced ejection fraction (HFrEF), and the CYCLE-2-PEF trial...

Robotic Endoscopy Device Market Set to Reach USD 10.0 Billion, with a Healthy 9.05% CAGR Till Forecasts 2035
The market is experiencing several emerging trends, such as the adoption of AI-enabled visualization and robotic control systems. US, NY, UNITED STATES, August 6, 2025 /EINPresswire.com/ -- Robotic Endoscopy Device Market Grows Amidst Rising...

Health Advisory: Cyanobacteria in the Charles River
Avoid Contact with Water Downstream of Harvard Bridge - Broad Canal, Lechmere Canal, North Point Park, Lederman Park, Community Boating docks, and Storrow Lagoon The Boston Public Health Commission (BPHC) is alerting residents of a cyanobacteria...

Attorney General Tong Sues to Block Unlawful Attacks on Medically Necessary Health Care for Transgender Youth
Press Releases 08/05/2025 Attorney General Tong Sues to Block Unlawful Attacks on Medically Necessary Health Care for Transgender Youth (Hartford, CT) — Attorney General William Tong today joined a multistate lawsuit challenging the Trump...

Inspire Medical Systems, Inc. Investors Who Have Lost Money Should Contact Block & Leviton to Find Out How They Might Recover Money Through The Firm’s Investigation
BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Inspire Medical Systems, Inc. (NYSE: INSP) for potential securities law violations. Investors who have lost money in their Inspire Medical Systems, Inc. investment should...

Amwell set to continue to enable U.S. Defense Health Agency healthcare teams to deliver connected and seamless in-person and virtual care for the Military Health System (“MHS”)
BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading technology-enabled care platform provider, announced that as part of a Leidos-led partnership, it has been awarded an extension of its next-generation Digital First contract...

Rhythm Pharmaceuticals Reports Second Quarter 2025 Financial Results and Business Update
-- Second quarter 2025 net product revenue from global sales of IMCIVREE® (setmelanotide) of $48.5 million -- -- U.S. and EU regulatory submissions for setmelanotide in acquired hypothalamic obesity on track to be completed in the third quarter of...

Boston Invited to Join the World Cities Culture Forum
In recognition of the City’s cultural diversity and strength, Boston becomes the next U.S. city to join a global network using culture to power economic growth, equity, and innovation. Mayor Michelle Wu announced that Boston has been officially...

Madrigal Pharmaceuticals Reports Second-Quarter 2025 Financial Results and Provides Corporate Updates
Second-quarter 2025 Rezdiffra™ (resmetirom) net sales of $212.8 million As of June 30, 2025, more than 23,000 patients on Rezdiffra Received new U.S. Rezdiffra patent providing protection to Feb. 4, 2045 Announced global licensing agreement for an...